| Similar Articles |
|---|
 |
The Motley Fool
August 23, 2010
Brian Orelli |
No Way to Jazz Up This Result Jazz Pharmaceuticals investors went from ecstatic to devastated in less than a week.   |
The Motley Fool
January 10, 2012
Sean Williams |
Could This Stock Nearly Double 2 Years In a Row? Up 96% in 2011, there's a decent chance at a Jazz Pharmaceuticals repeat in 2012. |
The Motley Fool
May 18, 2011
Sean Williams |
10 Mid Caps to Rule Them All The future of Jazz Pharmaceuticals' narcolepsy drug is so bright you may actually sleep better at night. |
The Motley Fool
October 11, 2010
Brian Orelli |
FDA Rejection, but Still Jazzed Up Sometimes, biotechs are like that. |
The Motley Fool
August 18, 2010
Brian Orelli |
No Pain Here as Jazz Shares Rocket Investors are all jazzed up about Jazz Pharmaceuticals |
The Motley Fool
April 27, 2011
Brian D. Pacampara |
Jazz Pharmaceuticals Shares Plunged then Recovered: What You Need to Know Shares of drug maker Jazz Pharmaceuticals suddenly plummeted 30% this morning only to quickly recover the majority of that loss. |
